Some Novel Anticonvulsant Agents Derived from Phthalazinedione

Abstract

A series of phthalazinedione bearing substituted oxadiazole moiety derivatives X(1–7) were synthesized in good yield and evaluated for their possible anticonvulsant activity. The structures of the synthesized compounds were confirmed on the basis of their spectral data and elemental analysis. Their anticonvulsant activities were evaluated by the maximal electroshock induced seizure (MES) and subcutaneous pentylenetetrazole (PTZ) tests. All the tested compounds showed considerable anticonvulsant activities in at least one of the anticonvulsant tests. Moreover, some of the tested compounds exhibited moderate anticonvulsant activities in both MES and PTZ tests. From these results,[3-)2-Alkoxycarbonylmethylthioxadiozol-5-yl)methyl -6-Iodophthalazine – 1,4- (2H,3H)-1,4-dion] (X1–7) derivatives could be recommended as novel structures of broad spectrum anticonvulsants.

Key words

antiepleptics - phthalazinedione - 1, 3, 4-oxadiazole

• References

• 1 Stefan H, Feuerstein JT. Novel anticonvulsant drugs. Pharmacol Ther 2007; 113: 165-183
• 2 Donner JE, Snead CO. New generation anticonvulsants for the treatment of epilepsy in children. NeuroRX 2006; 3: 170-180
• 3 Loscher W, Schmidt D. New horizons in the development of antiepileptic drugs. Epilepsy Res 2002; 50: 3-16
• 4 Loscher W, Schmidt D. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 2006; 69: 183-272
• 5 Greenwood SR. Adverse effects of antiepileptic drugs. Epilepsia 2000; 41: 42-52
• 6 Wong GM, Defina AJ, Andrews RP. Conformational analysis of clinically active anticonvulsant drugs. J Med Chem 1986; 29: 562-572
• 7 Pelletier CJ, Hesson PD, Jones AK et al. Substituted 1,2-dihydrophthalazines: Potent, selective, and noncompetitive inhibitors of the AMPA receptor. J Med Chem 1996; 39: 343-346
• 8 Grasso S, Sarro DG, Sarro DA et al. Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones. J Med Chem 2000; 43: 2851-2859
• 9 Xu W, Han F, He M et al. Inhibition of tobacco bacterial wilt with sulfone derivatives containing an 1,3,4-oxadiazole Moiety. J Agric Food Chem 2012; 60: 1036-1041
• 10 Bader H, Hoops FJ, Biel HJ et al. Antimalarial compounds related to diaminodiphenyl sulfone. J Med Chem 1969; 12: 709-711
• 11 Watjen F, Baker R, Engelstoff M et al. Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines. J Med Chem 1989; 32: 2282-2291
• 12 Jhal KK, Kumar Y, Shaharyar M et al. Microwave assisted synthesis, characterization & biological evaluation of Benzimidazole substituted1,3,4-oxadiazole. Int J ChemTech Res 2010; 2: 716-727
• 13 Singh P, Sharma KP, Sharma KJ et al. Synthesis and evaluation of substituted diphenyl-1,3,4-oxadiazole derivatives for central nervous system depressant activity. Org Med Chem Lett 2012; 2 (08) 1-10
• 14 Laznicek M, Beno P, Waisser K et al. Quantitative chemical structure-pharmacokinetic data relationships. IV. Relationships between pharmacokinetic data and lipophilicity of iodine-substituted aromatic and arylaliphatic compounds. Cesko-Slovenska Farmacie 1985; 34 (09) 353-358
• 15 Yanming W, Chester AM, Guo-Feng H et al. Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives. J mol neurosci 2003; 20 (03) 255-260
• 16 Sivakumar R, Gnanasam KS, Ramachandran S et al. Pharmacological evaluation of some new 1-substituted-4 hydroxyphthalazines. Eur J med Chem 2002; 37: 793-801
• 17 Parsons GC, Danysz W, Quack NG et al. Systemically Active Antagonists of the Glycine Site of the N-Methyl-D-aspartate Receptor: Electrophysiological, Biochemical and Behavioral Characterization. J Pharmacol Exp Ther 1997; 283: 1264-1275
• 18 Krall LR, Penary KJ, White GB et al. Antiepileptic drug development: II. anticonvulsant drug screening. Epilepsia 1978; 19: 409-428
• 19 Witak TD, Seth KS, Baizman RE et al. p-Substituted N-acetyl-L-(S)- and D(R)-.alpha.-amino-N phenylsuccinimides and -glutarimides. Substituent effects on stereoselective anticonvulsant activity. J Med Chem 1972; 15: 1117-1123